hg_114324.1

Basic information about the TSS

---

TSS ID: hg_114324.1 Species: human Chr: chr11		Start: 57741451 End: 57741498 Strand: +
TSS cluster detected*

  * The number of TSS cluster called studies (maximum 16)

Gene and protein annotation

---

Transcript_name: ENST00000534355.6 NM_170746 AJ276249 Distance: 0 GeneID: 280636 HGNC/MGI_ID: HGNC:18251 UniProt_ID: Q8IZQ5

Gene_name: selenoprotein H Gene_symbol: SELENOH Gene_synonyms: SELH Gene_source: HGNC:18251

TATA-Box annotation

---

Distance to TSS:	-16
Nearest PromoterID:	NM_170746
Entrez ID:	280636
Nearest Unigene:	Hs.655373
Nearest Refseq:	NM_170746
Nearest Ensembl:	ENSG00000211450
Gene Name:	selenoprotein H
Gene Alias:	C11orf31|C17orf10|SELH
Gene Description:	selenoprotein H
Gene Type:	protein-coding
CpG%:	0.065
GC%:	0.646766
TATA-Box(TBP)/Promoter/Homer Distance From TSS(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@SELENOH p2@SELENOH p3@SELENOH
Sample		p1@SELENOH	p2@SELENOH	p3@SELENOH
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	91.17	34.29	46.95
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	92.66	37.23	52.20
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	99.54	36.84	44.56
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	88.99	34.72	42.41
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	104.38	33.07	45.44
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	79.85	31.01	41.28
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	116.57	31.81	50.55
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	107.55	30.52	46.99
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	110.71	30.78	47.66
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	117.08	37.10	79.41
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	115.61	41.23	81.25
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	115.05	40.25	67.08
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	73.02	59.80	60.93
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	69.31	51.27	48.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	62.35	43.91	47.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	63.63	53.32	58.09
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	62.68	45.65	50.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	62.43	51.88	74.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	71.44	51.72	58.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	93.88	69.35	69.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	76.05	65.22	63.62
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	88.04	60.59	67.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	63.98	51.83	47.05
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	68.43	51.20	59.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	73.01	52.63	75.08
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	87.99	64.88	85.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	85.72	56.04	75.83
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	87.23	57.29	64.83
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	87.71	73.33	71.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	85.23	53.57	51.58
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	87.30	58.62	64.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	94.37	57.64	80.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	81.04	65.21	81.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	95.99	66.47	62.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	91.62	54.60	61.89
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	80.10	43.12	63.43
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	104.23	50.48	66.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	75.56	50.37	59.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	83.19	56.99	49.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	77.06	50.17	53.05
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	82.34	58.34	65.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	97.21	58.41	58.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	88.15	51.67	62.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	87.06	59.79	66.08
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	84.12	45.58	49.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	103.76	52.81	62.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	93.80	50.14	62.38
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	111.47	60.80	72.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	107.24	61.52	69.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	105.75	60.46	73.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	107.40	54.11	45.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	115.19	48.70	57.37
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	97.95	41.98	13.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	57.49	31.94	31.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	71.91	39.77	35.79
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	84.73	26.85	34.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	130.42	40.87	34.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	82.00	22.36	30.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	62.95	29.23	26.01
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	171.62	31.75	30.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	51.47	38.78	32.43
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	50.47	37.01	29.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	148.08	26.27	22.29
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	142.36	31.60	46.89
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	63.03	19.50	27.62
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	71.00	24.85	35.14
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	64.66	32.33	32.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	134.26	102.67	31.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	39.00	27.30	19.01
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	54.05	28.76	25.79
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	63.33	28.62	20.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	92.73	29.14	16.89
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	44.55	32.17	20.11
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	46.17	30.27	17.73
Adipocyte - breast, donor1	11376-118A8	39.28	44.51	24.07
Adipocyte - breast, donor2	11327-117E4	29.52	51.82	18.45
Adipocyte - omental, donor1	11473-119C6	30.28	25.57	17.68
Adipocyte - omental, donor2	11474-119C7	40.36	49.33	18.69
Adipocyte - omental, donor3	11475-119C8	39.52	43.54	11.39
Adipocyte - perirenal, donor1	11476-119C9	49.76	69.54	29.35
Adipocyte - subcutaneous, donor1	11259-116F8	16.49	50.58	19.79
Adipocyte - subcutaneous, donor2	11336-117F4	22.58	25.29	11.29
Adipocyte - subcutaneous, donor3	11408-118E4	11.64	32.15	14.42
Adipocyte differentiation, day04, donor1	13019-139D4	15.25	22.30	13.49
Adipocyte differentiation, day04, donor2	13022-139D7	30.37	29.34	16.47
Adipocyte differentiation, day04, donor3	13025-139E1	14.22	25.93	14.22
Adipocyte differentiation, day04, donor4	13028-139E4	25.28	27.04	17.05
Adipocyte differentiation, day08, donor1	13020-139D5	12.63	24.05	12.79
Adipocyte differentiation, day08, donor2	13023-139D8	19.69	26.79	12.26
Adipocyte differentiation, day08, donor3	13026-139E2	16.53	19.19	5.33
Adipocyte differentiation, day08, donor4	13029-139E5	13.35	15.58	8.90
Adipocyte differentiation, day12, donor1	13021-139D6	13.72	25.37	10.40
Adipocyte differentiation, day12, donor2	13024-139D9	10.30	27.13	11.30
Adipocyte differentiation, day12, donor3	13027-139E3	14.07	32.72	8.18
Adipocyte differentiation, day12, donor4	13030-139E6	8.53	16.75	7.00
Alveolar Epithelial Cells, donor1	11510-119G7	93.04	63.87	47.74
Alveolar Epithelial Cells, donor2	11590-120G6	108.65	136.98	91.44
Alveolar Epithelial Cells, donor3	11671-122G6	49.12	38.34	17.97
Amniotic Epithelial Cells, donor1	11533-120A3	60.45	65.31	41.74
Amniotic Epithelial Cells, donor2	11613-122A2	83.67	60.25	50.20
Amniotic Epithelial Cells, donor3	11694-123A2	41.50	67.39	40.27
Anulus Pulposus Cell, donor1	11248-116E6	46.00	54.47	46.80
Anulus Pulposus Cell, donor2	11463-119B5	42.12	51.68	32.08
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	44.48	42.23	31.90
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	47.32	47.76	28.22
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	44.95	40.66	29.96
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	45.14	42.15	29.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	51.85	50.59	25.29
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	38.28	42.90	33.66
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	42.56	39.64	37.04
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	42.72	50.49	29.61
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	38.01	46.32	32.66
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	49.34	45.95	37.29
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	52.25	57.33	42.09
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	37.61	52.66	31.34
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	42.50	44.31	36.57
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	49.13	42.31	31.39
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	37.25	50.52	30.46
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	48.22	46.08	37.51
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	45.16	50.45	27.77
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	44.90	59.60	30.47
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	47.80	47.80	16.58
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	44.45	39.97	29.69
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	39.62	63.64	33.62
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	56.64	38.94	24.78
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	47.34	41.17	27.62
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	46.14	67.12	29.36
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	48.06	45.14	29.13
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	53.50	55.40	29.98
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	35.13	43.61	27.86
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	40.47	38.19	30.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	46.82	37.41	25.65
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	44.91	44.91	30.97
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	42.23	48.80	25.81
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	44.05	44.05	24.76
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	47.09	52.08	32.11
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	35.68	53.23	26.32
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	44.26	51.18	23.48
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	39.20	48.71	36.83
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	47.80	46.28	35.09
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	51.96	46.61	29.80
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	38.76	52.10	36.85
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	41.86	47.04	31.07
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	41.28	47.84	23.92
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	39.44	52.49	29.87
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	47.24	52.91	44.40
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	42.89	49.67	30.18
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	23.16	46.33	30.11
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	46.48	38.03	25.35
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	53.60	51.03	31.09
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	41.51	48.73	27.68
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	45.93	40.82	30.62
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	56.32	45.98	28.51
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	43.36	51.01	25.50
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	42.71	60.76	31.02
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	51.61	53.67	36.54
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	45.59	53.24	30.29
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	47.32	42.07	32.03
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	46.34	41.24	27.72
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	50.35	44.25	41.20
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	48.19	52.07	28.80
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	43.16	42.90	24.10
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	47.25	50.16	26.90
Astrocyte - cerebellum, donor1	11500-119F6	188.15	52.32	77.13
Astrocyte - cerebellum, donor2	11580-120F5	181.94	57.51	75.99
Astrocyte - cerebellum, donor3	11661-122F5	97.32	41.11	67.75
Astrocyte - cerebral cortex, donor1	11235-116D2	134.21	42.88	58.56
Astrocyte - cerebral cortex, donor2	11316-117D2	133.14	33.81	58.56
Astrocyte - cerebral cortex, donor3	11392-118C6	136.03	30.88	48.03
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	147.14	45.53	43.35
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	149.34	40.59	47.73
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	154.19	39.03	49.39
Basophils, donor1	12241-129G9	23.01	54.14	7.32
Basophils, donor2	12242-129H1	27.42	42.57	9.74
Basophils, donor3	12243-129H2	15.14	42.92	12.20
Bronchial Epithelial Cell, donor1	11511-119G8	15.95	59.94	14.45
Bronchial Epithelial Cell, donor2	11591-120G7	53.03	122.98	36.57
Bronchial Epithelial Cell, donor3	11672-122G7	21.52	136.30	21.52
Bronchial Epithelial Cell, donor4	11453-119A4	33.89	52.10	42.05
Bronchial Epithelial Cell, donor5	11457-119A8	20.80	39.51	24.12
Bronchial Epithelial Cell, donor6	11461-119B3	21.88	46.29	14.28
Bronchial Epithelial Cell, donor7	11769-123I5	14.58	53.80	13.14
Burkitt's lymphoma cell line:DAUDI	10422-106C8	103.26	42.56	50.50
Burkitt's lymphoma cell line:RAJI	10476-106I8	19.10	8.62	11.88
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	362.62	44.45	73.23
CD133+ stem cells - cord blood derived, pool1	12223-129E9	392.99	20.68	51.71
CD14+ Monocytes, donor1	11224-116B9	10.71	35.50	11.83
CD14+ Monocytes, donor2	11305-117B9	13.36	28.58	10.21
CD14+ Monocytes, donor3	11381-118B4	16.90	35.35	13.61
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	27.74	97.93	32.55
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	45.87	94.39	31.84
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	24.66	71.01	21.70
CD14+ monocytes - mock treated, donor1	11863-125A9	15.18	50.16	14.60
CD14+ monocytes - mock treated, donor2	11873-125C1	16.60	47.07	6.03
CD14+ monocytes - mock treated, donor3	11883-125D2	20.37	57.09	13.03
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	11.72	33.81	9.71
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	15.73	33.40	8.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	16.86	38.68	7.44
CD14+ monocytes - treated with BCG, donor1	11860-125A6	10.96	41.90	12.73
CD14+ monocytes - treated with BCG, donor2	11870-125B7	11.40	42.02	7.83
CD14+ monocytes - treated with BCG, donor3	11880-125C8	24.37	72.91	13.28
CD14+ monocytes - treated with Candida, donor1	11868-125B5	7.73	38.40	5.15
CD14+ monocytes - treated with Candida, donor2	11878-125C6	8.45	34.85	5.28
CD14+ monocytes - treated with Candida, donor3	11888-125D7	11.09	42.16	7.77
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	12.94	41.65	10.11
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	15.96	37.32	7.98
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	24.36	59.54	11.24
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	12.13	41.41	8.47
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	18.32	37.55	8.60
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	12.66	40.15	8.73
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	12.37	47.61	9.68
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	16.22	48.67	9.42
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	18.52	53.87	12.20
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	7.35	32.15	6.98
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	13.39	30.29	5.64
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	16.67	32.47	5.70
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	10.11	40.28	9.42
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	16.35	37.17	11.15
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	24.57	55.18	10.99
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	11.06	36.85	6.96
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	11.82	29.90	6.26
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	14.15	49.41	9.05
CD14+CD16+ Monocytes, donor1	11789-124B7	12.21	78.25	11.99
CD14+CD16+ Monocytes, donor2	11801-124D1	19.17	153.38	26.10
CD14+CD16+ Monocytes, donor3	11912-125G4	30.76	177.62	30.33
CD14+CD16- Monocytes, donor1	11788-124B6	12.46	76.30	16.04
CD14+CD16- Monocytes, donor2	11799-124C8	14.32	130.46	26.72
CD14+CD16- Monocytes, donor3	11910-125G2	16.50	84.95	18.28
CD14-CD16+ Monocytes, donor1	11790-124B8	13.52	141.37	16.84
CD14-CD16+ Monocytes, donor2	11800-124C9	15.15	154.13	19.32
CD14-CD16+ Monocytes, donor3	11911-125G3	16.63	171.17	23.79
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	294.68	77.23	56.90
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	220.34	79.32	61.70
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	272.36	88.03	54.89
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	216.41	132.73	50.11
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	265.35	88.99	54.14
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	247.78	89.15	47.03
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	269.03	94.12	64.32
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	340.12	96.23	59.32
CD19+ B Cells, donor1	11544-120B5	117.53	26.30	21.37
CD19+ B Cells, donor2	11624-122B4	62.39	23.21	15.96
CD19+ B Cells, donor3	11705-123B4	82.29	26.25	20.70
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	21.01	73.54	15.35
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	21.17	96.28	16.78
CD34+ Progenitors, donor1	11545-120B6	141.57	28.11	47.19
CD34+ Progenitors, donor2	11625-122B5	129.78	21.35	14.61
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	230.71	57.11	70.27
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	313.87	66.52	61.11
CD4+ T Cells, donor1	11225-116C1	54.27	24.28	24.99
CD4+ T Cells, donor2	11306-117C1	56.95	31.84	12.86
CD4+ T Cells, donor3	11382-118B5	46.05	32.02	25.01
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	36.75	55.13	27.31
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	86.25	108.48	71.42
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	68.99	95.44	58.07
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	107.14	47.41	27.02
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	174.88	110.97	53.38
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	164.81	62.63	49.44
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	29.63	41.48	20.52
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	52.36	100.32	52.03
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	48.36	92.05	43.85
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	41.69	26.00	16.14
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	59.40	61.84	31.44
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	73.48	24.64	19.36
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	48.49	62.40	28.67
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	88.09	134.43	55.06
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	89.55	129.31	67.16
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	85.66	47.04	33.18
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	145.78	95.40	48.24
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	147.04	77.11	66.35
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	50.44	62.49	33.38
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	62.17	81.45	40.51
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	52.33	64.94	39.51
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	64.21	43.99	22.75
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	88.82	99.21	46.36
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	95.44	55.35	30.07
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	192.01	92.54	48.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	217.87	75.70	36.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	276.37	80.96	62.81
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	183.05	76.99	35.72
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	230.18	74.35	43.68
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	189.42	77.00	40.04
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	155.06	67.33	33.66
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	210.52	90.02	51.24
CD8+ T Cells, donor1	11226-116C2	61.22	18.99	14.41
CD8+ T Cells, donor2	11307-117C2	43.55	19.15	10.14
CD8+ T Cells, donor3	11383-118B6	78.78	13.89	14.39
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	141.76	8.72	15.60
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	118.62	7.67	12.94
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	111.63	4.38	17.24
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	104.77	9.31	11.41
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	129.11	9.36	14.64
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	131.88	7.28	13.42
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	155.58	7.17	11.73
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	150.03	4.47	12.11
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	155.48	6.10	9.85
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	175.39	6.94	18.11
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	175.76	10.75	18.01
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	176.91	6.39	15.45
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	85.36	7.00	4.82
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	85.62	3.64	9.56
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	68.62	4.48	2.24
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	133.98	6.48	9.72
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	119.40	8.06	10.36
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	126.80	7.31	11.31
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	137.22	6.02	10.14
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	140.56	5.23	13.84
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	121.18	4.49	10.90
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	162.55	4.97	13.39
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	156.46	7.09	14.58
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	168.68	6.81	10.59
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	100.37	20.88	17.67
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	132.89	25.18	15.39
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	128.22	18.03	25.04
Cardiac Myocyte, donor1	11525-119I4	43.87	14.62	18.28
Cardiac Myocyte, donor2	11605-120I3	98.82	45.95	54.35
Cardiac Myocyte, donor3	11686-122I3	55.35	32.94	28.94
Chondrocyte - de diff, donor1	11261-116G1	44.03	35.36	24.61
Chondrocyte - de diff, donor2	11338-117F6	15.28	41.22	15.64
Chondrocyte - de diff, donor3	11410-118E6	25.94	39.94	27.08
Chondrocyte - re diff, donor2	11339-117F7	87.74	88.63	51.03
Chondrocyte - re diff, donor3	11411-118E7	35.59	45.29	27.10
Ciliary Epithelial Cells, donor1	11242-116D9	153.55	36.84	54.28
Ciliary Epithelial Cells, donor2	11323-117D9	150.70	32.71	47.03
Ciliary Epithelial Cells, donor3	11399-118D4	151.95	25.66	44.43
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	49.79	40.26	28.24
Corneal Epithelial Cells, donor1	11526-119I5	34.69	83.00	29.20
Corneal Epithelial Cells, donor2	11606-120I4	21.61	63.71	17.06
Corneal Epithelial Cells, donor3	11687-122I4	37.07	64.16	32.72
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	154.69	71.98	17.00
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	163.70	77.59	21.45
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	169.08	79.37	27.61
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	157.66	52.91	13.50
Dendritic Cells - plasmacytoid, donor1	11228-116C4	158.86	45.78	53.30
Dendritic Cells - plasmacytoid, donor2	11309-117C4	237.64	88.14	77.69
Dendritic Cells - plasmacytoid, donor3	11385-118B8	254.07	55.65	53.23
Endothelial Cells - Aortic, donor0	11207-116A1	57.87	30.19	38.52
Endothelial Cells - Aortic, donor1	11263-116G3	58.68	32.27	47.53
Endothelial Cells - Aortic, donor2	11340-117F8	96.43	41.01	57.41
Endothelial Cells - Aortic, donor3	11412-118E8	84.53	27.52	47.97
Endothelial Cells - Artery, donor1	11264-116G4	75.05	27.63	39.56
Endothelial Cells - Artery, donor2	11341-117F9	92.93	21.88	31.53
Endothelial Cells - Artery, donor3	11413-118E9	48.56	24.19	30.33
Endothelial Cells - Lymphatic, donor1	11236-116D3	83.78	41.45	48.76
Endothelial Cells - Lymphatic, donor2	11317-117D3	71.50	33.77	41.38
Endothelial Cells - Lymphatic, donor3	11393-118C7	73.58	18.89	32.42
Endothelial Cells - Microvascular, donor1	11265-116G5	88.84	43.68	44.87
Endothelial Cells - Microvascular, donor2	11342-117G1	76.02	57.27	59.36
Endothelial Cells - Microvascular, donor3	11414-118F1	69.90	27.08	45.51
Endothelial Cells - Thoracic, donor1	11266-116G6	123.24	54.02	64.82
Endothelial Cells - Thoracic, donor2	11343-117G2	61.85	37.74	47.70
Endothelial Cells - Umbilical vein, donor1	11243-116E1	138.53	32.43	70.94
Endothelial Cells - Umbilical vein, donor2	11324-117E1	146.43	27.16	52.58
Endothelial Cells - Umbilical vein, donor3	11400-118D5	151.19	25.89	55.08
Endothelial Cells - Vein, donor1	11267-116G7	80.76	17.06	53.46
Endothelial Cells - Vein, donor2	11344-117G3	58.67	23.75	30.73
Endothelial Cells - Vein, donor3	11416-118F3	125.13	38.62	60.60
Eosinophils, donor1	12244-129H3	91.48	45.74	0.00
Eosinophils, donor2	12245-129H4	11.55	4.95	0.00
Eosinophils, donor3	12246-129H5	7.13	14.27	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	21.99	69.88	21.26
Esophageal Epithelial Cells, donor2	11587-120G3	10.40	47.84	6.24
Esophageal Epithelial Cells, donor3	11668-122G3	0.00	97.61	16.27
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	43.10	36.95	21.35
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	26.61	52.55	27.26
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	66.63	59.04	54.93
Fibroblast - Aortic Adventitial, donor1	11245-116E3	65.98	42.57	40.99
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	11.87	33.84	11.19
Fibroblast - Aortic Adventitial, donor2	11326-117E3	52.73	48.20	28.37
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	27.93	24.50	15.02
Fibroblast - Aortic Adventitial, donor3	11401-118D6	67.10	39.53	32.89
Fibroblast - Cardiac, donor1	11268-116G8	67.14	40.83	31.75
Fibroblast - Cardiac, donor2	11345-117G4	34.11	42.45	14.40
Fibroblast - Cardiac, donor3	11417-118F4	77.12	52.68	54.25
Fibroblast - Cardiac, donor4	11452-119A3	53.35	25.46	20.61
Fibroblast - Cardiac, donor5	11456-119A7	89.85	37.94	32.74
Fibroblast - Cardiac, donor6	11460-119B2	88.53	29.71	32.29
Fibroblast - Choroid Plexus, donor1	11492-119E7	82.54	33.63	35.51
Fibroblast - Choroid Plexus, donor2	11572-120E6	53.07	21.14	24.16
Fibroblast - Choroid Plexus, donor3	11653-122E6	109.86	36.62	41.01
Fibroblast - Conjunctival, donor1	11531-120A1	103.33	69.42	81.18
Fibroblast - Conjunctival, donor3	11692-122I9	40.20	34.43	25.27
Fibroblast - Dermal, donor1	11269-116G9	50.71	42.73	24.89
Fibroblast - Dermal, donor2	11346-117G5	49.05	53.77	46.22
Fibroblast - Dermal, donor3	11418-118F5	70.72	56.09	37.11
Fibroblast - Dermal, donor4	11450-119A1	56.97	38.21	33.24
Fibroblast - Dermal, donor5	11454-119A5	67.34	38.21	39.60
Fibroblast - Dermal, donor6	11458-119A9	78.45	37.84	35.73
Fibroblast - Gingival, donor1	11237-116D4	25.20	44.56	27.90
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	56.33	41.13	36.16
Fibroblast - Gingival, donor2	11318-117D4	65.10	52.85	43.49
Fibroblast - Gingival, donor3	11394-118C8	19.53	31.71	20.69
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	58.18	29.09	19.74
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	32.77	28.19	19.38
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	79.66	47.24	40.22
Fibroblast - Gingival, donor6 (control)	11922-125H5	55.44	43.00	32.73
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	51.87	26.47	50.81
Fibroblast - Gingival, donor7 (control)	11924-125H7	61.13	49.87	47.24
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	54.00	42.95	40.09
Fibroblast - Gingival, donor8 (control)	11926-125H9	77.55	33.13	48.37
Fibroblast - Gingival, donor9 (control)	11927-125I1	39.33	29.49	26.12
Fibroblast - Lung, donor1	11270-116H1	47.58	21.75	24.47
Fibroblast - Lung, donor2	11347-117G6	47.75	31.34	50.73
Fibroblast - Lung, donor3	11419-118F6	89.69	54.87	52.34
Fibroblast - Lymphatic, donor1	11506-119G3	114.12	76.64	45.82
Fibroblast - Lymphatic, donor2	11586-120G2	26.57	55.95	16.78
Fibroblast - Lymphatic, donor3	11667-122G2	46.18	43.38	35.26
Fibroblast - Mammary, donor1	11540-120B1	83.63	41.00	66.58
Fibroblast - Mammary, donor2	11620-122A9	111.84	79.88	35.95
Fibroblast - Mammary, donor3	11701-123A9	35.74	29.78	35.74
Fibroblast - Periodontal Ligament, donor1	11238-116D5	58.77	56.45	54.31
Fibroblast - Periodontal Ligament, donor2	11319-117D5	65.68	31.25	51.88
Fibroblast - Periodontal Ligament, donor3	11395-118C9	19.58	28.46	25.70
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	44.27	30.91	23.66
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	42.93	47.25	23.22
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	36.76	31.66	21.46
Fibroblast - Pulmonary Artery, donor1	11250-116E8	74.83	48.08	42.22
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	76.81	59.33	49.78
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	81.52	68.82	64.15
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	60.09	45.07	39.14
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	20.84	16.67	10.32
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	28.60	40.32	17.05
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	59.91	32.91	21.09
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	27.68	27.68	9.33
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	73.95	37.03	23.32
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	15.18	26.07	13.92
Fibroblast - skin normal, donor1	11553-120C5	42.66	49.55	26.09
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	12.63	19.65	11.83
Fibroblast - skin normal, donor2	11561-120D4	70.22	35.97	24.21
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	17.83	25.99	11.18
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	34.38	39.85	24.27
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	62.23	41.37	23.93
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	19.38	20.69	8.54
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	59.33	41.22	27.27
Fibroblast - skin walker warburg, donor1	11554-120C6	68.99	52.63	35.09
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	44.69	25.25	18.03
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	0.00	22.16	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	11.33	47.93	7.84
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	20.98	92.05	26.00
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	24.46	59.33	20.82
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	21.21	48.80	17.37
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	365.93	62.01	141.63
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	372.63	64.45	141.65
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	601.91	80.73	173.44
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	334.22	41.92	118.02
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	212.80	33.11	78.77
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	398.64	51.71	122.84
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	305.31	35.42	108.91
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	177.75	32.94	77.62
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	597.00	49.53	111.44
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	202.80	37.45	88.75
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	158.11	33.13	80.04
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	210.33	35.19	74.68
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	158.71	19.45	73.59
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	184.25	24.78	74.61
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	167.32	20.33	50.01
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	154.02	28.52	66.86
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	132.41	25.54	65.15
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	123.28	28.63	51.80
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	181.72	40.19	77.71
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	144.33	27.50	82.66
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	127.57	39.55	62.33
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	140.54	27.02	61.70
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	141.31	27.82	78.04
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	132.92	33.07	41.85
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	97.92	25.70	43.60
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	92.05	18.96	41.33
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	120.39	22.79	63.18
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	125.79	33.69	48.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	132.11	39.82	48.80
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	133.89	33.01	58.80
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	120.60	22.37	58.22
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	125.41	28.35	49.36
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	127.63	32.40	68.33
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	135.91	25.95	63.59
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	119.30	30.31	48.79
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	109.04	45.54	58.69
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	115.98	30.42	64.53
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	127.33	28.95	47.45
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	120.72	34.36	43.18
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	127.43	24.67	54.57
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	109.34	48.74	45.67
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	106.33	45.45	46.85
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	83.24	28.98	46.20
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	108.83	35.03	44.92
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	98.23	34.27	40.55
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	97.02	31.35	48.06
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	76.98	36.32	40.66
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	95.31	32.81	38.53
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	83.56	39.26	46.06
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	62.48	26.78	43.64
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	67.54	34.69	35.88
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	64.76	34.50	30.67
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	41.94	21.86	31.77
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	253.40	43.20	76.84
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	185.97	33.28	86.28
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	233.22	37.23	100.25
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	425.27	83.24	162.10
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	371.56	85.61	178.29
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	303.93	57.65	97.31
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	386.07	76.72	118.79
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	373.27	55.31	109.85
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	394.70	93.06	139.59
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	335.59	71.29	107.81
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	308.23	61.52	113.92
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	290.32	62.59	93.89
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	236.59	33.32	106.63
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	264.55	52.29	98.72
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	271.93	51.31	81.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	219.78	36.91	96.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	273.54	46.12	92.24
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	269.01	51.97	100.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	323.66	83.53	123.20
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	278.33	52.69	105.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	230.57	48.54	94.71
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	249.04	54.21	89.79
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	326.40	55.50	89.05
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	311.59	42.80	94.81
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	421.48	31.61	147.52
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	254.87	42.29	76.11
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	216.12	40.09	71.71
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	257.50	40.80	108.35
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	223.46	44.31	94.01
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	251.62	35.95	66.76
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	144.12	32.30	69.57
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	178.83	33.03	67.95
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	213.03	34.40	71.82
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	193.81	46.29	89.53
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	219.36	35.50	73.79
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	198.82	30.59	67.59
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	185.33	51.94	67.29
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	200.71	38.51	85.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	135.61	32.92	59.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	142.41	28.82	42.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	198.77	36.41	59.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	213.51	39.31	68.91
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	25.11	38.80	28.53
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	33.27	27.03	19.54
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	29.24	39.36	31.48
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	28.54	40.28	23.15
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	23.81	62.24	21.30
Hep-2 cells mock treated, biol_rep1	11898-125E8	35.62	51.17	29.59
Hep-2 cells mock treated, biol_rep2	11899-125E9	38.82	54.02	23.13
Hep-2 cells mock treated, biol_rep3	11900-125F1	37.77	44.59	23.89
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	38.26	56.62	28.86
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	34.39	56.95	23.64
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	35.95	44.99	24.97
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	39.60	52.55	34.75
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	30.71	44.60	23.16
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	31.72	55.10	23.39
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	230.01	41.97	72.19
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	132.87	38.09	62.76
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	97.82	31.73	47.59
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	106.87	46.91	44.80
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	130.05	45.04	55.21
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	89.34	48.78	39.51
Hepatocyte, donor1	11523-119I2	21.79	110.16	41.16
Hepatocyte, donor2	11603-120I1	24.78	100.19	43.09
Hepatocyte, donor3	11684-122I1	27.61	87.12	23.93
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	246.06	39.16	64.62
Intestinal epithelial cells (polarized), donor1	11246-116E4	56.80	94.03	40.55
Iris Pigment Epithelial Cells, donor1	11530-119I9	72.45	31.28	40.89
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	54.13	44.57	41.39
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	40.05	53.40	20.03
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	81.25	81.25	27.08
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	41.53	48.45	18.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	25.03	42.55	22.52
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	47.47	130.55	23.74
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	48.70	46.13	28.19
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	54.85	73.13	41.14
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	42.23	73.09	34.11
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	58.36	48.35	26.68
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	32.68	54.46	7.26
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	54.26	50.29	26.47
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	70.95	42.13	36.59
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	68.10	52.38	20.95
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	39.68	59.21	45.35
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	38.67	47.95	23.20
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	14.63	73.17	14.63
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	47.16	54.91	33.59
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	37.03	37.03	24.15
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	71.69	35.84	59.74
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	39.11	41.56	32.60
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	23.93	46.18	29.39
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	14.37	14.37	43.12
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	46.61	48.22	32.15
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	48.01	54.47	23.08
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	30.16	45.24	15.08
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	49.56	60.42	47.20
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	34.47	61.67	21.77
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	29.48	58.97	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	38.74	53.81	35.51
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	41.93	62.25	21.60
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	49.29	16.43	49.29
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	39.54	41.45	33.16
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	60.15	60.15	36.45
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	63.22	63.22	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	28.56	44.27	26.42
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	23.23	43.14	6.64
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	41.70	62.55	20.85
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	49.39	50.93	41.36
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	36.88	33.36	29.85
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	25.15	47.15	25.15
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	41.03	39.64	29.21
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	33.20	66.39	35.41
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	38.90	87.53	35.66
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	34.88	44.47	34.01
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	33.75	62.99	36.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	27.88	34.85	13.94
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	39.47	61.87	45.87
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	41.56	34.64	29.09
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	45.59	42.74	34.20
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	34.06	52.46	38.66
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	45.38	81.68	33.28
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	24.83	62.09	49.67
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	35.95	52.87	51.81
Keratinocyte - epidermal, donor1	11272-116H3	14.04	30.19	14.12
Keratinocyte - epidermal, donor2	11349-117G8	9.37	41.58	13.47
Keratinocyte - epidermal, donor3	11421-118F8	30.10	52.72	33.89
Keratinocyte - oral, donor1	11251-116E9	32.47	65.27	25.43
Keratocytes, donor1	11527-119I6	96.27	90.77	61.55
Keratocytes, donor2	11607-120I5	78.51	70.31	48.04
Keratocytes, donor3	11688-122I5	16.80	46.44	24.30
Krukenberg tumor cell line:HSKTC	10687-109F3	50.55	101.10	6.59
Lens Epithelial Cells, donor1	11529-119I8	74.43	33.44	37.76
Lens Epithelial Cells, donor2	11609-120I7	92.03	41.40	52.36
Lens Epithelial Cells, donor3	11690-122I7	47.93	20.48	23.51
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	113.48	45.77	60.83
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	98.51	36.28	59.72
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	93.97	44.39	65.01
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	108.62	68.83	56.46
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	103.69	45.07	63.98
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	103.93	51.75	72.88
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	92.34	46.37	52.53
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	110.99	53.09	76.86
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	98.95	50.95	62.49
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	91.76	46.67	54.58
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	114.78	44.40	63.79
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	109.24	56.84	71.47
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	108.36	45.99	57.14
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	101.61	50.57	72.03
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	100.13	51.92	67.85
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	110.56	48.04	63.13
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	114.10	58.61	78.56
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	106.50	56.54	73.56
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	108.28	50.35	60.89
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	121.25	47.74	77.61
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	103.06	61.98	81.90
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	104.27	48.01	66.44
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	113.10	45.78	65.17
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	114.14	49.65	64.03
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	110.94	55.47	63.76
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	108.46	39.99	65.96
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	114.13	47.82	70.37
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	123.13	48.15	64.66
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	99.34	47.23	62.84
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	117.27	47.40	72.84
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	107.58	45.55	55.73
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	98.58	48.30	50.61
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	120.55	45.10	63.80
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	134.76	48.50	56.27
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	102.54	40.03	58.31
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	115.08	48.12	72.87
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	101.64	48.89	56.29
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	104.69	40.48	60.56
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	118.55	43.81	66.34
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	107.74	46.93	55.47
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	108.11	42.18	76.11
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	123.09	56.17	80.45
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	124.26	54.43	63.74
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	91.80	38.55	65.33
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	115.59	58.39	70.63
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	104.08	40.71	53.21
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	89.64	42.26	62.24
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	133.96	45.35	71.31
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	22.66	38.52	15.86
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	26.08	42.96	15.34
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	25.24	34.14	16.33
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	35.54	43.58	16.50
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	26.02	45.72	20.40
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	30.82	53.24	20.55
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	24.73	39.16	11.34
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	23.79	48.77	15.46
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	22.62	51.80	16.96
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	46.24	50.31	18.03
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	45.92	54.02	17.56
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	28.99	39.16	16.66
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	33.38	40.05	17.97
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	35.99	49.75	18.35
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	43.98	48.64	15.99
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	40.75	41.26	12.23
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	41.09	45.62	22.41
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	35.33	57.63	20.97
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	34.36	42.34	12.88
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	30.99	46.48	13.86
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	35.40	53.94	22.07
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	41.48	45.40	20.46
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	39.15	30.91	5.15
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	35.42	58.93	20.32
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	40.36	46.93	15.25
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	41.49	47.58	20.47
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	29.69	37.12	10.96
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	33.19	29.87	15.12
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	26.48	35.69	13.82
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	33.00	42.60	17.65
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	24.91	42.46	17.55
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	27.90	48.41	11.49
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	31.18	41.57	16.27
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	25.85	35.91	20.11
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	39.59	25.39	26.14
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	32.33	39.02	12.63
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	34.46	47.81	11.20
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	27.40	35.96	13.70
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	28.65	38.32	13.33
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	28.96	42.23	12.67
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	29.15	47.64	15.64
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	26.12	39.18	16.84
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	34.35	33.82	11.27
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	20.87	34.34	18.18
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	29.26	41.12	14.82
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	27.91	43.03	17.44
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	27.50	44.43	11.64
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	33.21	37.21	16.01
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	26.17	47.97	8.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	20.70	49.82	16.10
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	28.61	45.87	14.31
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	28.23	31.05	12.23
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	25.14	47.77	10.06
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	25.23	45.51	14.87
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	27.54	25.82	13.77
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	29.39	34.29	13.81
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	22.68	44.58	16.81
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	25.07	38.92	12.53
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	29.06	43.07	18.16
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	31.94	37.63	13.13
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	24.04	42.49	15.65
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	31.36	42.40	12.37
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	30.09	45.51	21.21
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	41.01	45.07	10.13
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	31.72	43.74	19.22
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	33.79	46.91	15.90
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	39.50	30.38	13.98
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	28.36	47.73	11.07
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	32.30	39.52	18.24
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	36.15	45.44	11.88
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	42.93	39.91	18.74
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	41.51	35.49	16.16
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	31.99	31.99	7.46
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	25.29	37.93	11.49
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	31.37	31.88	17.48
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	32.54	29.00	12.73
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	31.78	43.13	12.48
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	27.04	28.29	15.39
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	24.27	34.45	10.18
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	30.06	36.74	18.79
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	26.02	30.67	13.01
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	26.76	32.11	11.37
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	37.96	39.56	17.11
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	29.09	33.94	9.70
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	22.03	29.37	13.77
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	26.67	36.45	8.89
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	28.49	37.61	11.97
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	22.24	32.98	9.97
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	38.85	38.85	12.59
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	27.62	30.74	12.92
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	20.54	34.31	12.74
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	33.16	48.41	17.24
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	45.73	22.86	10.39
Macrophage - monocyte derived, donor1	11232-116C8	41.02	127.18	33.50
Macrophage - monocyte derived, donor2	11313-117C8	160.20	38.35	18.53
Macrophage - monocyte derived, donor3	11389-118C3	104.47	73.14	24.38
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	34.52	114.70	25.49
Mallassez-derived cells, donor2	11929-125I3	24.88	61.48	21.55
Mallassez-derived cells, donor3	11930-125I4	36.55	71.02	27.80
Mammary Epithelial Cell, donor1	11273-116H4	43.34	68.75	30.49
Mammary Epithelial Cell, donor2	11350-117G9	40.25	57.04	31.56
Mammary Epithelial Cell, donor3	11422-118F9	19.95	39.66	20.70
Mast cell - stimulated, donor1	11487-119E2	140.33	8.81	49.49
Mast cell, donor1	11563-120D6	88.46	42.07	33.85
Mast cell, donor2	11565-120D8	65.08	34.18	21.69
Mast cell, donor3	11566-120D9	67.31	52.90	27.92
Mast cell, donor4	11567-120E1	62.23	46.80	20.03
Mast cell, expanded and stimulated, donor5	11940-126A5	197.06	25.84	24.73
Mast cell, expanded and stimulated, donor8	11942-126A7	252.73	17.51	21.60
Mast cell, expanded, donor5	11939-126A4	91.55	85.81	50.02
Mast cell, expanded, donor8	11941-126A6	122.35	50.04	38.83
Melanocyte - dark, donor1	11502-119F8	119.40	41.89	74.23
Melanocyte - dark, donor2	11582-120F7	100.02	50.18	42.57
Melanocyte - dark, donor3	11663-122F7	111.05	42.74	36.44
Melanocyte - light, donor1	11274-116H5	42.08	30.09	18.57
Melanocyte - light, donor2	11351-117H1	40.27	45.73	27.98
Melanocyte - light, donor3	11423-118G1	34.69	33.82	20.81
Melanocyte, donor1 (MC+1)	12641-134G4	92.78	50.19	44.98
Melanocyte, donor2 (MC+2)	12739-135I3	133.13	62.39	37.92
Melanocyte, donor3 (MC+3)	12837-137B2	92.14	65.62	47.95
Meningeal Cells, donor1	11493-119E8	120.34	29.90	53.84
Meningeal Cells, donor2	11573-120E7	153.61	34.33	47.98
Meningeal Cells, donor3	11654-122E7	89.57	29.59	44.50
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	108.93	55.32	50.19
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	76.48	38.94	22.24
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	39.42	113.02	60.45
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	122.97	87.65	79.80
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	104.77	41.62	41.62
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	48.71	40.45	23.51
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	58.31	31.16	23.12
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	128.56	68.12	57.58
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	146.85	57.72	65.75
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	121.94	68.95	60.15
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	34.77	60.25	22.44
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	95.90	75.83	46.09
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	35.79	45.39	25.53
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	65.28	72.11	48.07
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	79.41	77.07	67.73
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	131.28	69.16	69.16
Mesenchymal stem cells - adipose, donor0	11217-116B2	103.85	49.27	46.79
Mesenchymal stem cells - hepatic, donor0	11218-116B3	37.84	49.10	21.58
Mesenchymal stem cells - umbilical, donor0	11214-116A8	106.68	76.92	78.37
Mesothelial Cells, donor1	11247-116E5	38.72	75.04	26.78
Mesothelial Cells, donor2	12156-128G5	34.03	58.55	25.52
Mesothelial Cells, donor3	11402-118D7	39.02	34.69	22.55
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	132.33	20.25	5.40
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	135.70	34.72	16.99
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	182.56	34.75	22.08
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	100.26	10.37	3.46
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	85.24	29.75	12.09
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	147.48	35.89	20.12
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	39.37	11.58	2.32
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	137.89	40.54	12.51
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	177.35	41.43	23.27
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	97.33	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	130.06	36.38	14.23
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	168.28	34.45	16.23
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	145.38	17.10	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	76.99	30.97	15.04
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	184.65	40.27	21.28
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	59.22	6.58	7.90
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	82.98	34.59	10.82
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	95.77	18.42	11.05
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	81.67	27.72	9.54
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	95.57	20.12	8.38
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	33.95	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	82.30	34.37	15.81
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	132.38	28.76	15.69
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	69.11	11.06	6.08
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	91.18	36.61	11.97
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	134.83	29.66	21.03
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	81.53	15.29	7.95
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	92.90	38.40	15.23
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	133.60	22.23	11.11
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	30.96	10.32	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	68.11	26.94	10.73
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	101.90	14.19	10.14
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	54.68	19.88	11.60
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	75.01	20.11	6.79
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	127.63	21.76	16.17
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	55.61	11.99	2.18
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	54.78	27.39	13.46
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	136.88	30.42	12.01
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	52.11	4.11	2.74
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	64.57	31.54	9.51
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	80.84	107.79	80.84
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	55.04	6.12	2.04
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	81.02	32.84	11.39
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	98.23	11.04	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	70.44	5.76	2.56
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	87.52	25.04	9.17
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	90.47	16.70	9.74
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	75.14	2.21	8.84
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	82.05	31.45	18.80
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	96.71	10.07	7.44
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	67.82	6.39	3.55
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	83.32	21.04	11.50
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	121.36	17.04	6.65
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	50.70	5.24	5.83
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	48.87	15.08	7.54
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	130.64	21.29	12.94
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	72.19	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	36.94	20.32	3.69
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	109.27	19.35	10.81
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	63.15	11.05	8.84
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	58.83	22.29	10.88
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	102.95	12.44	7.72
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	46.37	7.62	4.45
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	44.30	15.75	9.61
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	95.49	30.23	8.98
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	45.48	15.26	11.87
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	58.61	30.90	13.70
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	111.67	19.90	13.05
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	49.30	12.13	9.10
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	47.45	23.86	17.61
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	105.45	22.37	15.49
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	55.39	12.38	9.78
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	43.22	27.64	16.17
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	103.80	32.00	20.47
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	67.18	32.97	16.07
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	58.96	38.71	17.27
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	22.60	150.68	41.44
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	40.99	65.94	28.52
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	33.19	56.51	23.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	85.21	61.01	28.40
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	28.47	52.39	12.85
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	70.78	28.87	10.24
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	44.31	30.04	11.27
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	74.04	31.96	7.72
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	31.44	86.18	18.10
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	51.57	47.15	11.79
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	24.55	44.70	19.79
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	65.34	54.45	10.89
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	70.55	141.63	37.41
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	42.50	42.50	15.46
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	22.22	39.39	21.21
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	107.94	64.51	26.14
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	91.25	185.22	40.86
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	134.79	99.18	26.07
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	80.17	115.81	31.58
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	131.41	95.16	33.23
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	79.94	125.62	68.52
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	420.86	65.25	35.89
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	156.83	57.03	19.01
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	213.33	50.20	12.55
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	61.18	37.27	32.10
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	41.29	28.22	23.52
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	28.03	22.03	22.03
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	37.15	15.44	13.36
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	143.18	18.63	27.95
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	140.44	44.68	43.09
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	18.36	21.08	10.88
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	64.32	14.70	33.08
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	34.32	25.53	24.69
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	69.96	31.38	25.80
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	31.62	19.46	22.43
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	63.49	41.84	39.52
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	66.81	55.67	44.54
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	30.28	26.80	36.23
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	98.79	27.07	28.15
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	28.56	30.83	23.35
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	48.34	19.11	20.90
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	71.44	54.68	43.01
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	23.34	23.87	36.07
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	30.62	15.01	20.41
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	132.26	25.93	32.82
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	27.16	23.42	16.59
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	63.67	43.57	41.45
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	44.30	30.24	25.32
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	49.19	21.15	21.61
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	47.24	26.35	21.85
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	88.64	14.83	16.55
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	106.19	0.00	25.28
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	61.93	42.55	29.85
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	69.86	19.05	26.67
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	49.61	16.85	14.72
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	43.35	21.89	18.46
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	54.17	36.11	18.06
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	43.99	17.66	21.99
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	44.64	40.58	25.25
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	46.43	19.84	19.05
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	23.22	20.43	18.57
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	107.46	30.27	24.22
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	36.17	16.62	11.08
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	25.28	11.77	10.89
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	62.42	42.06	26.23
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	27.34	16.76	10.58
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	20.61	18.62	12.63
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	33.73	22.82	24.31
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	26.80	11.10	11.10
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	81.96	22.99	18.15
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	68.74	43.98	26.08
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	29.82	10.16	21.01
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	40.88	45.99	35.77
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	47.56	31.09	33.53
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	38.71	14.16	11.02
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	34.50	11.50	13.01
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	26.11	23.73	15.03
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	103.16	18.14	12.47
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	55.64	15.17	10.12
Myoblast, donor1	11241-116D8	47.70	56.40	32.30
Myoblast, donor2	11322-117D8	101.84	54.85	40.85
Myoblast, donor3	11398-118D3	62.89	50.45	42.55
NK T cell leukemia cell line:KHYG-1	10777-110G3	120.10	41.74	42.17
Natural Killer Cells, donor1	11230-116C6	51.97	26.14	16.61
Natural Killer Cells, donor2	11311-117C6	36.79	19.00	11.46
Natural Killer Cells, donor3	11387-118C1	41.41	18.22	13.25
Neural stem cells, donor1	11275-116H6	125.94	13.43	32.66
Neural stem cells, donor2	11352-117H2	113.61	25.03	46.22
Neurons, donor1	11494-119E9	178.65	45.52	70.55
Neurons, donor2	11574-120E8	115.81	34.57	50.64
Neurons, donor3	11655-122E8	204.72	27.13	50.15
Neutrophils, donor1	11233-116C9	2.78	3.71	3.71
Neutrophils, donor2	11314-117C9	2.90	2.90	0.00
Neutrophils, donor3	11390-118C4	0.61	3.05	1.22
Nucleus Pulposus Cell, donor1	11252-116F1	36.81	31.58	35.26
Nucleus Pulposus Cell, donor2	11409-118E5	48.51	55.35	51.45
Nucleus Pulposus Cell, donor3	11462-119B4	63.58	50.14	32.29
Olfactory epithelial cells, donor1	11933-125I7	33.04	17.21	15.55
Olfactory epithelial cells, donor2	11934-125I8	41.11	27.65	19.54
Olfactory epithelial cells, donor3	11935-125I9	26.56	26.90	17.25
Olfactory epithelial cells, donor4	11936-126A1	21.14	17.04	11.88
Oligodendrocyte - precursors, donor1	11496-119F2	36.11	37.91	21.67
Osteoblast - differentiated, donor1	11276-116H7	23.40	26.37	14.25
Osteoblast - differentiated, donor2	11353-117H3	36.58	85.73	35.44
Osteoblast - differentiated, donor3	11425-118G3	36.00	65.17	52.76
Osteoblast, donor1	11277-116H8	98.70	40.65	63.32
Osteoblast, donor2	11354-117H4	80.77	25.28	33.01
Osteoblast, donor3	11426-118G4	63.45	28.08	31.10
Pancreatic stromal cells, donor1	11249-116E7	51.80	53.66	37.23
Pericytes, donor1	11491-119E6	86.12	54.19	49.85
Pericytes, donor2	11571-120E5	143.74	45.95	54.78
Pericytes, donor3	11652-122E5	77.72	60.63	42.52
Perineurial Cells, donor1	11499-119F5	35.60	28.82	28.71
Perineurial Cells, donor2	11579-120F4	77.75	38.64	42.14
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	51.00	56.10	22.95
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	36.73	45.30	15.67
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	31.71	27.82	12.17
Placental Epithelial Cells, donor1	11278-116H9	27.98	70.31	20.81
Placental Epithelial Cells, donor2	11355-117H5	48.79	80.95	37.70
Placental Epithelial Cells, donor3	11427-118G5	64.98	44.17	48.49
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	51.90	31.65	23.10
Preadipocyte - breast, donor1	11467-119B9	35.27	52.15	22.51
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	13.44	18.40	6.66
Preadipocyte - breast, donor2	11328-117E5	58.76	56.06	28.37
Preadipocyte - omental, donor1	11468-119C1	41.66	53.60	30.05
Preadipocyte - omental, donor2	11329-117E6	45.39	55.87	29.68
Preadipocyte - omental, donor3	11403-118D8	86.09	49.71	35.53
Preadipocyte - perirenal, donor1	11469-119C2	62.01	71.85	38.39
Preadipocyte - subcutaneous, donor1	11279-116I1	67.57	19.96	21.50
Preadipocyte - subcutaneous, donor2	11356-117H6	185.22	35.59	41.08
Preadipocyte - subcutaneous, donor3	11428-118G6	152.92	35.42	26.05
Preadipocyte - visceral, donor1	11280-116I2	102.09	31.76	31.76
Preadipocyte - visceral, donor2	11357-117H7	110.44	37.27	35.89
Preadipocyte - visceral, donor3	11429-118G7	126.75	40.86	29.05
Prostate Epithelial Cells (polarized), donor1	11253-116F2	67.88	68.94	31.98
Prostate Epithelial Cells, donor2	11331-117E8	30.60	51.05	21.12
Prostate Epithelial Cells, donor3	11404-118D9	5.76	64.54	9.12
Prostate Stromal Cells, donor1	11254-116F3	70.62	50.00	32.92
Prostate Stromal Cells, donor2	11332-117E9	102.56	51.46	39.45
Prostate Stromal Cells, donor3	11405-118E1	57.35	47.03	33.26
Renal Cortical Epithelial Cells, donor1	11516-119H4	79.57	87.23	66.43
Renal Cortical Epithelial Cells, donor2	11596-120H3	31.26	44.22	23.01
Renal Epithelial Cells, donor1	11517-119H5	94.34	79.64	85.72
Renal Epithelial Cells, donor2	11597-120H4	145.82	53.35	61.88
Renal Epithelial Cells, donor3	11678-122H4	42.45	39.38	31.44
Renal Glomerular Endothelial Cells, donor1	11514-119H2	212.43	59.91	63.32
Renal Glomerular Endothelial Cells, donor2	11594-120H1	141.50	49.73	61.72
Renal Glomerular Endothelial Cells, donor3	11675-122H1	117.44	30.86	37.96
Renal Glomerular Endothelial Cells, donor4	11783-124B1	204.29	43.25	109.13
Renal Mesangial Cells, donor1	11518-119H6	133.81	50.18	67.57
Renal Mesangial Cells, donor2	11598-120H5	123.52	58.94	54.55
Renal Mesangial Cells, donor3	11679-122H5	112.63	49.38	64.64
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	71.40	72.74	53.15
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	61.15	60.72	37.53
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	125.16	54.77	69.23
Retinal Pigment Epithelial Cells, donor0	11215-116A9	66.89	67.93	52.89
Retinal Pigment Epithelial Cells, donor1	11528-119I7	131.61	59.12	63.39
Retinal Pigment Epithelial Cells, donor2	11608-120I6	165.69	63.81	65.86
Retinal Pigment Epithelial Cells, donor3	11689-122I6	48.93	55.95	33.37
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	31.40	69.89	26.73
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	67.90	71.47	33.06
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	42.93	52.84	27.52
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	82.95	51.04	42.92
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	68.26	40.44	33.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	59.78	41.11	44.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	55.88	51.20	45.95
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	62.52	37.46	32.62
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	67.60	48.72	40.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	57.09	50.85	49.92
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	61.61	40.25	33.95
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	59.90	37.82	36.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	56.27	61.64	43.01
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	67.71	41.17	37.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	56.23	42.50	40.46
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	66.16	44.25	46.02
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	69.59	29.06	32.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	50.21	38.20	35.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	55.81	42.84	40.78
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	65.96	28.80	29.73
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	60.64	39.91	34.65
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	51.94	47.17	43.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	66.00	35.03	34.81
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	59.71	37.56	34.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	63.40	46.31	36.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	63.82	36.47	32.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	59.97	37.03	37.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	57.62	46.47	43.92
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	71.47	41.28	43.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	58.14	38.89	39.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	61.97	51.45	45.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	71.95	47.69	41.26
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	60.83	42.25	32.74
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	55.98	48.46	36.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	70.52	38.36	35.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	61.31	32.87	35.93
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	54.95	39.52	44.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	74.62	39.89	39.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	54.46	35.80	32.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	59.43	41.70	40.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	72.09	35.79	32.72
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	71.61	37.43	58.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	57.84	39.18	45.31
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	92.50	38.16	37.06
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	62.14	45.72	41.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	65.30	32.85	47.77
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	81.84	39.55	31.08
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	85.94	64.98	47.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	98.82	56.21	53.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	80.53	41.61	37.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	84.86	65.64	39.59
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	67.54	72.40	54.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	79.87	42.80	32.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	68.99	59.94	45.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	66.80	55.12	35.05
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	81.83	63.88	37.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	65.53	73.21	46.32
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	58.90	67.31	30.65
Schwann Cells, donor1	11498-119F4	140.30	67.14	75.23
Schwann Cells, donor2	11578-120F3	68.05	54.44	27.22
Schwann Cells, donor3	11659-122F3	72.08	40.53	46.01
Sebocyte, donor1	11220-116B5	16.98	28.48	24.65
Sebocyte, donor2	11301-117B5	34.01	29.87	17.46
Sebocyte, donor3	11378-118B1	16.90	41.63	17.73
Sertoli Cells, donor1	11255-116F4	53.01	41.41	19.88
Sertoli Cells, donor2	11333-117F1	56.49	53.66	8.47
Skeletal Muscle Cells, donor1	11281-116I3	73.99	47.24	51.64
Skeletal Muscle Cells, donor2	11358-117H8	40.48	27.47	17.35
Skeletal Muscle Cells, donor3	11430-118G8	69.39	41.80	59.36
Skeletal Muscle Cells, donor4	11451-119A2	145.63	44.77	39.90
Skeletal Muscle Cells, donor5	11455-119A6	123.82	38.50	42.07
Skeletal Muscle Cells, donor6	11459-119B1	108.96	42.17	34.17
Skeletal Muscle Satellite Cells, donor1	11240-116D7	61.87	50.02	42.09
Skeletal Muscle Satellite Cells, donor2	11321-117D7	76.05	42.95	41.38
Skeletal Muscle Satellite Cells, donor3	11397-118D2	122.72	40.68	45.93
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	84.34	24.52	33.53
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	67.31	47.77	62.97
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	70.45	24.77	28.90
Skin - palm, donor1	10286-104F7	24.17	18.80	13.43
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	21.48	35.32	20.33
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	23.72	28.63	7.36
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	26.48	28.43	18.18
Small Airway Epithelial Cells, donor1	11256-116F5	24.74	60.47	13.90
Small Airway Epithelial Cells, donor2	11334-117F2	35.02	39.95	12.94
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	16.28	28.12	10.15
Small Airway Epithelial Cells, donor3	11406-118E2	14.77	41.52	9.59
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	61.72	56.16	28.70
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	14.67	12.67	4.89
Smooth Muscle Cells - Aortic, donor0	11210-116A4	35.86	51.14	31.15
Smooth Muscle Cells - Aortic, donor1	11283-116I5	30.94	23.87	23.65
Smooth Muscle Cells - Aortic, donor2	11360-117I1	46.47	72.06	54.34
Smooth Muscle Cells - Aortic, donor3	11432-118H1	45.58	63.35	37.86
Smooth Muscle Cells - Bladder, donor1	11519-119H7	99.07	38.03	46.03
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	30.61	39.79	29.28
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	66.72	42.78	27.26
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	54.03	45.32	33.16
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	67.72	39.72	38.75
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	64.09	36.92	37.51
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	52.39	51.11	32.46
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	54.33	46.52	36.44
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	30.44	42.01	22.22
Smooth Muscle Cells - Carotid, donor1	11285-116I7	43.19	28.03	24.50
Smooth Muscle Cells - Carotid, donor2	11362-117I3	18.36	48.97	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	29.09	42.44	27.18
Smooth Muscle Cells - Colonic, donor1	11239-116D6	52.21	46.01	31.56
Smooth Muscle Cells - Colonic, donor2	11320-117D6	62.63	41.33	37.45
Smooth Muscle Cells - Colonic, donor3	11396-118D1	65.07	45.13	40.62
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	43.93	66.36	53.98
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	35.57	63.59	35.57
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	54.69	62.76	45.72
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	131.78	78.86	84.33
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	40.44	45.47	36.52
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	22.04	33.31	12.58
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	71.00	37.55	30.72
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	48.30	54.95	28.98
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	112.86	57.75	59.08
Smooth Muscle Cells - Prostate, donor1	11257-116F6	71.91	49.93	34.89
Smooth Muscle Cells - Prostate, donor2	11335-117F3	71.12	52.34	38.32
Smooth Muscle Cells - Prostate, donor3	11465-119B7	36.02	48.20	23.08
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	57.75	35.28	26.99
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	43.51	37.51	24.76
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	69.78	19.38	21.97
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	37.21	27.44	19.07
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	33.83	65.63	38.88
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	21.62	44.19	21.00
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	30.68	29.20	25.07
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	77.56	58.48	48.40
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	45.78	37.37	34.57
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	29.22	44.47	24.03
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	71.64	53.03	44.87
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	75.40	48.51	46.44
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	65.82	45.14	42.76
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	44.49	48.93	33.52
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	59.52	128.09	60.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	26.42	48.20	25.93
Smooth Muscle Cells - Uterine, donor1	11258-116F7	136.77	39.99	27.62
Smooth Muscle Cells - Uterine, donor3	11466-119B8	67.00	51.79	32.48
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	23.91	31.10	19.44
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	30.94	43.11	17.72
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	18.97	39.80	9.67
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	24.43	42.76	18.33
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	39.75	70.69	24.13
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	77.59	47.66	38.21
Smooth muscle cells - airway, control, donor1	11966-126D4	37.84	31.49	20.82
Smooth muscle cells - airway, control, donor2	11967-126D5	26.75	19.97	19.57
Smooth muscle cells - airway, control, donor3	11968-126D6	33.44	50.58	25.50
Smooth muscle cells - airway, control, donor4	11969-126D7	33.00	43.09	20.63
Synoviocyte, donor1	11291-117A4	50.83	38.21	22.39
Synoviocyte, donor2	11368-117I9	30.68	56.99	28.50
Synoviocyte, donor3	11440-118H9	31.50	46.69	19.21
Trabecular Meshwork Cells, donor1	11532-120A2	134.36	64.32	82.90
Trabecular Meshwork Cells, donor2	11612-122A1	63.43	83.25	37.66
Trabecular Meshwork Cells, donor3	11693-123A1	125.96	56.96	73.40
Tracheal Epithelial Cells, donor1	11292-117A5	18.71	54.19	30.25
Tracheal Epithelial Cells, donor2	11369-118A1	22.42	39.43	22.42
Tracheal Epithelial Cells, donor3	11441-118I1	18.33	34.93	15.46
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	33.09	70.12	26.20
Urethra, donor2	10319-105A4	23.38	30.57	21.58
Urothelial Cells, donor1	11520-119H8	24.97	70.67	22.05
Urothelial Cells, donor2	11600-120H7	26.04	67.29	21.23
Urothelial Cells, donor3	11681-122H7	21.09	62.80	19.48
Urothelial cells, donor0	11216-116B1	20.28	49.26	13.37
Whole blood (ribopure), donor090309, donation1	12179-129A1	61.40	36.48	12.46
Whole blood (ribopure), donor090309, donation2	12180-129A2	64.33	78.63	18.58
Whole blood (ribopure), donor090309, donation3	12181-129A3	39.70	34.91	13.69
Whole blood (ribopure), donor090325, donation1	12176-128I7	54.41	49.93	23.76
Whole blood (ribopure), donor090325, donation2	12177-128I8	62.75	54.62	27.31
Whole blood (ribopure), donor090612, donation1	12182-129A4	46.86	47.90	14.58
Whole blood (ribopure), donor090612, donation2	12183-129A5	67.92	63.33	18.36
Whole blood (ribopure), donor090612, donation3	12184-129A6	48.38	52.04	20.08
Wilms' tumor cell line:G-401	10809-111A8	112.51	19.49	39.72
Wilms' tumor cell line:HFWT	10597-108E3	59.84	21.12	20.24
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	57.26	137.70	43.29
achilles tendon, donor2	10292-104G4	22.73	22.73	14.47
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	256.49	48.44	83.37
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	139.54	13.70	35.29
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	151.12	26.47	66.71
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	386.67	47.62	131.16
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	399.42	30.92	96.69
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	500.36	155.65	140.63
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	259.15	54.99	65.06
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	247.20	50.67	57.28
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	241.34	37.57	73.91
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	200.75	53.59	73.00
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	92.00	63.85	75.07
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	171.62	19.50	46.81
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	349.27	35.32	85.05
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	98.38	64.21	67.57
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	111.34	65.46	65.46
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	55.31	46.94	34.86
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	108.57	121.73	79.37
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	69.98	110.50	51.57
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	156.60	105.82	113.50
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	106.76	118.89	84.01
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	133.11	121.56	95.08
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	188.44	141.44	148.12
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	154.77	83.39	79.72
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	278.73	24.16	68.75
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	226.00	59.14	89.27
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	237.26	11.78	54.95
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	254.93	24.37	56.23
adenocarcinoma cell line:IM95m	10796-110I4	18.60	76.30	25.90
adipose tissue, adult, pool1	10010-101C1	19.55	24.82	12.41
adipose, donor1	10184-103D4	504.31	24.63	55.12
adipose, donor2	10185-103D5	127.74	25.55	49.47
adipose, donor3	10186-103D6	186.79	23.96	60.72
adipose, donor4	10187-103D7	330.23	38.14	71.94
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	351.62	65.02	126.41
adrenal gland, adult, pool1	10081-102A9	14.55	40.01	21.83
adult T-cell leukemia cell line:ATN-1	10421-106C7	22.28	46.96	22.95
alveolar cell carcinoma cell line:SW 1573	10708-109H6	92.90	49.66	42.52
amniotic membrane cells, donor1	12235-129G3	5.56	61.90	6.26
amniotic membrane cells, donor2	12236-129G4	24.68	104.81	19.95
amniotic membrane cells, donor3	12237-129G5	4.71	66.29	3.83
amygdala - adult, donor10196	10167-103B5	101.98	41.50	26.09
amygdala, adult, donor10252	10151-102I7	59.21	33.66	17.24
amygdala, newborn, donor10223	10360-105E9	79.40	29.69	23.88
anaplastic carcinoma cell line:8305C	10428-106D5	44.69	44.57	33.62
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	128.62	74.13	73.47
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	281.26	17.04	21.38
aorta, adult, pool1	10052-101G7	21.18	23.73	13.34
appendix, adult	10189-103D9	73.74	41.92	29.89
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	217.71	29.92	54.00
artery, adult	10190-103E1	16.30	66.58	14.95
astrocytoma cell line:TM-31	10425-106D2	183.40	38.24	57.08
b cell line:RPMI1788	10427-106D4	121.64	44.76	65.73
basal cell carcinoma cell line:TE 354.T	10702-109G9	41.06	60.48	18.31
bile duct carcinoma cell line:HuCCT1	10432-106D9	40.39	62.22	33.94
bile duct carcinoma cell line:TFK-1	10496-107C1	2.18	18.91	4.35
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	53.13	138.69	72.14
bladder, adult, pool1	10011-101C2	16.62	37.05	12.82
blood, adult, pool1	10053-101G8	26.58	37.65	11.07
bone marrow stromal cell line:StromaNKtert	10686-109F2	38.54	59.09	22.27
bone marrow, adult	10192-103E3	74.91	42.51	26.32
brain, adult, donor1	10084-102B3	59.45	41.00	17.43
brain, adult, pool1	10012-101C3	57.46	40.42	25.28
brain, fetal, pool1	10085-102B4	114.87	64.11	66.78
breast carcinoma cell line:MCF7	10482-107A5	72.68	60.46	36.01
breast carcinoma cell line:MDA-MB-453	10419-106C5	20.60	114.46	35.95
breast, adult, donor1	10080-102A8	13.26	17.68	10.10
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	74.32	90.83	48.66
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	107.61	87.20	60.30
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	104.98	87.25	55.25
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	26.15	49.63	16.70
carcinoid cell line:NCI-H1770	10703-109H1	69.58	65.35	53.60
carcinoid cell line:NCI-H727	10735-110B6	44.08	85.64	42.11
carcinoid cell line:SK-PN-DW	10719-109I8	59.26	10.46	21.23
carcinosarcoma cell line:JHUCS-1	10642-109A3	183.13	28.21	56.96
caudate nucleus - adult, donor10196	10177-103C6	73.68	42.60	16.12
caudate nucleus, adult, donor10252	10164-103B2	63.75	45.35	23.26
caudate nucleus, adult, donor10258	10379-105H1	155.12	74.12	49.67
caudate nucleus, newborn, donor10223	10354-105E3	75.44	42.85	23.81
cerebellum - adult, donor10196	10173-103C2	23.31	40.79	14.57
cerebellum, adult, donor10252	10166-103B4	12.38	30.96	19.00
cerebellum, adult, pool1	10083-102B2	15.52	35.53	20.35
cerebellum, newborn, donor10223	10357-105E6	19.10	32.38	16.61
cerebral meninges, adult	10188-103D8	92.54	50.68	24.96
cerebrospinal fluid, donor2	10294-104G6	29.97	21.93	13.89
cervical cancer cell line:D98-AH2	10552-107I3	21.28	50.76	19.84
cervical cancer cell line:ME-180	10553-107I4	42.42	59.33	19.89
cervix, adult, pool1	10013-101C4	25.09	42.21	18.06
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	44.59	63.82	43.89
chondrosarcoma cell line:SW 1353	10700-109G7	31.35	13.06	9.14
choriocarcinoma cell line:BeWo	10423-106C9	10.07	11.56	8.20
choriocarcinoma cell line:SCH	10785-110H2	48.92	28.34	19.71
choriocarcinoma cell line:T3M-3	10618-108G6	102.70	114.08	62.62
chorionic membrane cells, donor1	12238-129G6	18.23	74.36	13.68
chorionic membrane cells, donor2	12239-129G7	63.14	59.26	33.91
chorionic membrane cells, donor3	12240-129G8	17.58	81.32	19.23
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	241.34	41.40	38.37
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	277.77	42.84	63.01
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	295.66	83.00	93.77
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	57.01	60.61	43.91
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	56.84	64.10	46.92
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	79.82	63.93	54.77
chronic myelogenous leukemia cell line:K562	10454-106G4	66.25	71.55	36.51
chronic myelogenous leukemia cell line:KU812	10409-106B4	228.05	65.16	121.45
clear cell carcinoma cell line:JHOC-5	10638-108I8	47.32	58.97	25.37
clear cell carcinoma cell line:TEN	10636-108I6	62.81	94.91	30.54
colon carcinoma cell line:CACO-2	10513-107D9	103.60	31.67	31.48
colon carcinoma cell line:COLO-320	10420-106C6	89.32	31.17	63.09
colon, adult, donor1	10082-102B1	16.66	45.22	20.23
colon, adult, pool1	10014-101C5	19.98	54.64	22.56
colon, fetal, donor1	10070-101I7	32.14	30.90	12.98
common myeloid progenitor CMP, donor1	12130-128D6	142.09	27.50	36.67
common myeloid progenitor CMP, donor2	12134-128E1	475.70	50.07	175.26
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	137.68	12.32	11.47
cord blood derived cell line:COBL-a 24h infection	10453-106G3	164.36	6.34	14.94
cord blood derived cell line:COBL-a untreated	10449-106F8	184.16	6.63	18.90
corpus callosum, adult, pool1	10042-101F6	22.00	30.07	17.14
cruciate ligament, donor2	10295-104G7	19.45	17.02	9.73
diaphragm, fetal, donor1	10069-101I6	49.76	21.67	19.26
diencephalon, adult	10193-103E4	45.60	44.16	21.84
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	159.81	30.08	51.20
ductal cell carcinoma cell line:KLM-1	10438-106E6	53.60	88.22	36.16
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	40.20	29.13	21.18
ductus deferens, adult	10196-103E7	13.46	53.82	15.45
duodenum, fetal, donor1, tech_rep1	10071-101I8	66.25	41.77	25.92
duodenum, fetal, donor1, tech_rep2	10071-101I8	62.53	62.53	38.99
dura mater, adult, donor1	10041-101F5	30.39	31.80	17.43
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	156.78	52.85	69.06
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	87.55	35.68	42.99
embryonic pancreas cell line:1B2C6	10604-108F1	50.56	37.61	24.66
embryonic pancreas cell line:1C3D3	10605-108F2	49.04	68.72	32.09
embryonic pancreas cell line:1C3IKEI	10606-108F3	58.97	41.37	27.48
embryonic pancreas cell line:2C6	10603-108E9	66.99	70.93	24.96
endometrial carcinoma cell line:OMC-2	10497-107C2	77.77	17.77	23.46
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	50.93	106.02	51.83
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	46.64	49.21	22.51
epidermoid carcinoma cell line:A431	10426-106D3	52.69	81.59	33.24
epidermoid carcinoma cell line:Ca Ski	10431-106D8	50.15	69.40	41.79
epididymis, adult	10197-103E8	58.82	50.03	24.07
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	28.56	27.50	25.90
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	38.54	12.58	25.95
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	63.03	90.16	49.93
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	62.20	75.19	50.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	72.26	90.41	56.91
esophagus, adult, pool1	10015-101C6	14.65	54.15	17.31
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	207.27	27.80	79.90
eye - muscle inferior rectus, donor1	10272-104E2	28.97	16.90	7.24
eye - muscle lateral, donor2	10298-104H1	4.21	18.94	4.21
eye - muscle medial, donor2	10299-104H2	20.84	22.32	5.95
eye - muscle superior, donor2	10297-104G9	29.81	20.64	6.88
eye - vitreous humor, donor1	10268-104D7	49.55	13.12	17.49
eye, fetal, donor1	10054-101G9	31.27	30.76	22.88
fibrosarcoma cell line:HT-1080	10758-110E2	47.44	26.67	27.18
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	153.61	80.49	80.01
frontal lobe, adult, pool1	10040-101F4	79.94	50.01	31.06
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	53.74	66.66	40.83
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	12.44	24.14	9.88
gall bladder, adult	10198-103E9	22.69	53.36	18.83
gamma delta positive T cells, donor1	11937-126A2	100.93	40.26	28.99
gamma delta positive T cells, donor2	11938-126A3	80.67	41.08	20.92
gastric adenocarcinoma cell line:MKN1	10614-108G2	48.16	45.41	17.53
gastric adenocarcinoma cell line:MKN45	10612-108F9	21.28	82.40	22.44
gastric cancer cell line:AZ521	10549-107H9	105.59	38.53	73.12
gastric cancer cell line:GSS	10560-108A2	196.77	55.83	68.64
gastrointestinal carcinoma cell line:ECC12	10615-108G3	121.77	33.58	41.12
giant cell carcinoma cell line:LU65	10487-107B1	7.92	44.75	8.38
giant cell carcinoma cell line:Lu99B	10433-106E1	39.75	34.01	32.89
glassy cell carcinoma cell line:HOKUG	10688-109F4	40.16	77.57	29.68
glioblastoma cell line:A172, tech_rep1	10444-106F3	50.35	31.98	30.93
glioblastoma cell line:A172, tech_rep2	10444-106F3	47.89	35.25	36.94
glioblastoma cell line:T98G	10485-107A8	42.82	22.96	29.91
glioma cell line:GI-1	10413-106B8	53.30	35.73	36.02
globus pallidus - adult, donor10196	10175-103C4	36.45	32.80	19.68
globus pallidus, adult, donor10252	10161-103A8	23.68	47.35	17.82
globus pallidus, adult, donor10258	10367-105F7	79.41	30.12	12.32
globus pallidus, newborn, donor10223	10364-105F4	47.43	35.71	26.65
granulocyte macrophage progenitor, donor1	12131-128D7	173.75	51.39	56.28
granulocyte macrophage progenitor, donor2	12135-128E2	295.07	54.64	131.14
granulocyte macrophage progenitor, donor3	12139-128E6	350.18	88.85	109.76
granulosa cell tumor cell line:KGN	10624-108H3	70.08	21.76	17.60
hIPS +CCl2, biol_rep1	14383-156B9	293.37	53.26	82.18
hIPS +CCl2, biol_rep2	14384-156C1	249.21	39.32	77.73
hIPS +CCl2, biol_rep3	14385-156C2	345.23	55.39	75.36
hIPS, biol_rep1	14380-156B6	304.71	56.05	61.80
hIPS, biol_rep2	14381-156B7	311.38	52.81	97.39
hIPS, biol_rep3	14382-156B8	100.42	51.86	56.28
hairy cell leukemia cell line:Mo	10712-109I1	315.22	32.18	54.02
heart - mitral valve, adult	10205-103F7	33.19	28.10	14.95
heart - pulmonic valve, adult	10206-103F8	19.61	27.72	14.64
heart - tricuspid valve, adult	10207-103F9	48.29	29.14	15.82
heart, adult, diseased post-infarction, donor1	10050-101G5	52.65	43.06	22.65
heart, adult, diseased, donor1	10051-101G6	22.99	39.60	5.96
heart, adult, pool1	10016-101C7	16.56	51.51	18.63
heart, fetal, pool1	10046-101G1	45.38	22.28	23.72
hepatic mesenchymal tumor cell line:LI90	10778-110G4	53.37	30.54	18.20
hepatoblastoma cell line:HuH-6	10633-108I3	72.54	20.22	19.03
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	69.61	16.02	20.11
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	64.09	17.84	23.55
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	64.88	16.77	22.64
hepatoma cell line:Li-7	10484-107A7	15.01	19.57	16.90
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	173.66	34.37	48.74
hippocampus - adult, donor10196	10169-103B7	89.90	20.82	19.87
hippocampus, adult, donor10252	10153-102I9	40.21	32.04	20.00
hippocampus, adult, donor10258	10374-105G5	110.55	69.22	18.42
hippocampus, newborn, donor10223	10363-105F3	69.44	27.14	29.61
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	568.84	86.06	154.42
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	274.31	68.92	111.92
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	340.98	77.44	135.07
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	201.86	38.34	83.45
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	207.60	32.53	83.14
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	256.24	51.63	136.66
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	193.27	37.08	73.57
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	153.82	37.48	79.92
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	162.66	35.87	86.33
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	206.25	66.78	119.34
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	198.16	49.34	94.50
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	201.99	57.90	103.02
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	228.47	41.78	74.49
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	282.49	42.25	75.17
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	368.30	55.86	80.29
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	202.94	22.15	57.08
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	170.50	23.11	54.07
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	322.85	31.48	68.47
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	105.12	24.30	38.62
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	115.50	26.83	45.02
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	139.08	30.70	54.50
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	130.15	33.31	56.67
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	133.83	32.51	55.16
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	166.50	28.70	69.05
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	266.03	62.63	99.39
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	259.32	51.64	85.59
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	500.59	82.07	154.34
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	190.83	30.28	60.56
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	153.94	27.56	62.71
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	227.87	38.13	111.36
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	99.29	32.58	55.33
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	99.62	38.52	50.48
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	154.18	41.05	79.01
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	161.57	48.57	70.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	188.55	53.76	70.42
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	218.10	41.34	88.05
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	269.28	56.27	100.71
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	399.76	83.78	166.68
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	341.95	65.37	142.44
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	169.92	35.76	69.99
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	608.36	71.57	100.85
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	273.03	43.02	95.64
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	138.47	53.09	78.81
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	168.64	46.32	97.71
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	149.82	41.64	86.12
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	153.95	29.83	57.28
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	165.35	33.99	92.63
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	207.43	38.25	107.22
immature langerhans cells, donor1	11904-125F5	58.84	73.61	19.37
immature langerhans cells, donor2	11905-125F6	66.54	101.39	25.35
insula, adult, pool1	10039-101F3	92.17	46.37	30.28
keratoacanthoma cell line:HKA-1	10791-110H8	36.74	32.19	18.53
kidney, adult, pool1	10017-101C8	35.24	45.46	33.34
kidney, fetal, pool1	10045-101F9	67.62	30.70	35.30
large cell lung carcinoma cell line:IA-LM	10509-107D5	132.22	44.03	59.93
large cell lung carcinoma cell line:NCI-H460	10839-111E2	29.45	39.54	35.67
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	16.70	27.34	9.36
left atrium, adult, donor1	10079-102A7	22.88	21.79	15.26
left ventricle, adult, donor1	10078-102A6	23.77	21.74	12.14
leiomyoblastoma cell line:G-402	10721-110A1	108.08	23.53	25.45
leiomyoma cell line:10964C	10569-108B2	49.94	79.75	30.90
leiomyoma cell line:15242A	10570-108B3	45.65	70.65	26.09
leiomyoma cell line:15425	10571-108B4	46.62	69.69	33.51
leiomyosarcoma cell line:Hs 5.T	10722-110A2	44.45	69.84	31.75
lens epithelial cell line:SRA 01/04	10647-109A8	52.28	63.78	30.32
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	167.64	41.91	62.10
liposarcoma cell line:KMLS-1	10782-110G8	66.70	45.14	29.84
liposarcoma cell line:SW 872	10726-110A6	158.88	45.08	48.98
liver, adult, pool1	10018-101C9	26.25	62.39	29.33
liver, fetal, pool1	10086-102B5	54.56	31.98	29.16
locus coeruleus - adult, donor10196	10182-103D2	22.17	31.50	16.48
locus coeruleus, adult, donor10252	10165-103B3	25.10	47.24	23.07
locus coeruleus, adult, donor10258	10375-105G6	37.81	36.96	20.88
locus coeruleus, newborn, donor10223	10362-105F2	47.11	38.70	18.09
lung adenocarcinoma cell line:A549	10499-107C4	10.79	15.36	11.35
lung adenocarcinoma cell line:PC-14	10408-106B3	52.39	111.68	50.33
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	37.17	51.80	31.77
lung, adult, pool1	10019-101D1	24.33	40.64	19.14
lung, fetal, donor1	10068-101I5	99.32	49.95	36.53
lung, right lower lobe, adult, donor1	10075-102A3	59.57	29.33	16.95
lymph node, adult, donor1	10077-102A5	58.22	19.88	20.35
lymphangiectasia cell line:DS-1	10727-110A7	74.08	74.96	44.27
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	157.42	28.98	42.41
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	27.18	62.86	30.58
mature adipocyte, donor1	12231-129F8	13.76	59.49	13.32
mature adipocyte, donor2	12232-129F9	13.28	64.33	12.66
mature adipocyte, donor3	12233-129G1	10.19	69.93	9.48
mature adipocyte, donor4	12234-129G2	19.21	58.17	9.21
maxillary sinus tumor cell line:HSQ-89	10414-106B9	15.01	35.02	22.40
medial frontal gyrus - adult, donor10196	10170-103B8	95.88	47.38	31.58
medial frontal gyrus, adult, donor10252	10150-102I6	41.01	37.70	16.55
medial frontal gyrus, adult, donor10258	10368-105F8	122.31	73.39	38.76
medial frontal gyrus, newborn, donor10223	10352-105E1	150.98	31.99	21.75
medial temporal gyrus - adult, donor10196	10183-103D3	120.99	55.35	36.62
medial temporal gyrus, adult, donor10252	10156-103A3	50.51	37.35	17.61
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	127.13	69.35	26.97
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	86.12	71.77	43.06
medial temporal gyrus, newborn, donor10223	10353-105E2	119.52	39.12	30.15
medulla oblongata - adult, donor10196	10174-103C3	33.10	22.07	11.68
medulla oblongata, adult, donor10252	10155-103A2	19.35	37.00	13.93
medulla oblongata, adult, pool1	10038-101F2	23.67	31.59	18.20
medulla oblongata, newborn, donor10223	10361-105F1	35.76	32.29	31.59
medulloblastoma cell line:D283 Med	10838-111E1	101.41	17.49	53.14
medulloblastoma cell line:ONS-76	10759-110E3	94.39	61.99	52.58
melanoma cell line:COLO 679	10514-107E1	104.36	57.93	34.21
melanoma cell line:G-361	10465-106H6	67.87	34.75	22.53
meningioma cell line:HKBMM	10691-109F7	20.44	66.75	17.91
merkel cell carcinoma cell line:MKL-1	10843-111E6	187.69	29.08	76.66
merkel cell carcinoma cell line:MS-1	10844-111E7	176.79	56.25	91.77
mesenchymal precursor cell - adipose, donor1	11747-123G1	119.06	45.26	32.07
mesenchymal precursor cell - adipose, donor2	11748-123G2	94.71	26.18	20.18
mesenchymal precursor cell - adipose, donor3	11749-123G3	100.21	36.44	25.26
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	51.41	55.91	26.83
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	82.42	40.05	22.15
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	57.61	74.27	33.32
mesenchymal precursor cell - cardiac, donor1	11752-123G6	33.81	72.26	24.54
mesenchymal precursor cell - cardiac, donor2	11753-123G7	77.87	42.21	21.97
mesenchymal precursor cell - cardiac, donor3	11754-123G8	103.32	34.88	33.82
mesenchymal precursor cell - cardiac, donor4	11755-123G9	96.28	54.56	37.95
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	82.09	42.96	35.14
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	59.94	61.92	34.58
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	123.84	31.27	28.78
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	75.75	59.34	31.42
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	100.65	58.19	24.30
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	59.31	49.60	23.36
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	57.83	51.10	26.69
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	24.40	51.53	20.98
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	81.39	52.03	27.27
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	100.42	48.27	33.18
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	71.60	45.87	32.12
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	90.94	56.33	29.08
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	49.22	40.06	22.03
mesenchymal stem cell line:Hu5/E18	10568-108B1	75.78	57.26	38.73
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	59.37	48.41	25.57
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	44.51	48.85	34.28
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	45.02	47.90	29.05
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	45.29	45.90	31.12
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	44.72	47.07	33.89
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	48.74	55.51	35.54
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	46.37	44.80	31.83
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	44.95	47.27	34.75
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	96.61	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	61.14	55.09	33.17
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	40.83	46.85	32.80
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	45.91	44.71	31.49
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	52.07	41.80	32.27
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	44.64	52.36	36.59
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	44.62	45.44	30.29
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	47.68	52.41	31.79
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	60.16	87.50	43.75
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	51.65	67.14	61.98
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	52.62	55.21	38.65
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	66.93	37.83	24.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	53.84	61.30	42.11
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	56.43	60.52	34.35
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	41.98	60.25	33.04
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	46.17	75.55	39.88
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	32.78	60.60	41.73
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	19.07	52.44	38.14
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	50.99	52.77	33.80
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	45.08	74.33	40.21
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	81.16	81.16	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	47.50	55.10	33.57
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	20.00	50.70	25.87
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	12.90	30.09	21.49
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	39.92	35.93	23.95
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	37.88	41.33	24.11
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	23.63	39.52	21.19
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	22.24	31.78	19.07
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	13.56	24.76	24.17
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	20.26	28.99	17.46
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	18.71	36.09	18.71
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	47.31	33.11	13.01
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	25.68	33.38	28.25
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	31.67	35.80	15.14
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	15.83	51.95	19.79
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	31.40	33.65	14.58
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	26.08	58.52	19.08
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	21.36	59.64	28.61
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	15.26	56.70	32.71
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	22.81	49.42	17.74
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	18.21	66.15	15.17
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	31.63	81.34	31.63
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	12.36	67.54	22.24
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	20.83	58.73	17.66
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	19.15	38.29	17.20
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	22.41	66.21	13.24
mesodermal tumor cell line:HIRS-BM	10696-109G3	41.01	30.17	23.99
mesothelioma cell line:ACC-MESO-1	10493-107B7	13.94	63.31	24.10
mesothelioma cell line:ACC-MESO-4	10494-107B8	94.29	39.62	47.03
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	59.83	17.09	47.01
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	83.33	46.13	41.20
mesothelioma cell line:Mero-25	10850-111F4	125.96	40.85	70.81
mesothelioma cell line:Mero-41	10851-111F5	32.27	43.27	33.74
mesothelioma cell line:Mero-48a	10852-111F6	40.30	43.84	36.54
mesothelioma cell line:Mero-82	10853-111F7	82.78	45.47	39.95
mesothelioma cell line:Mero-83	10854-111F8	48.17	35.24	31.66
mesothelioma cell line:Mero-84	10855-111F9	148.88	55.61	66.99
mesothelioma cell line:Mero-95	10856-111G1	57.97	37.68	40.79
mesothelioma cell line:NCI-H2052	10847-111F1	57.81	39.59	35.45
mesothelioma cell line:NCI-H226	10846-111E9	47.06	22.08	22.99
mesothelioma cell line:NCI-H2452	10848-111F2	38.95	44.58	34.85
mesothelioma cell line:NCI-H28	10845-111E8	41.48	29.77	34.61
mesothelioma cell line:No36	10857-111G2	45.67	64.59	36.86
mesothelioma cell line:ONE58	10858-111G3	31.43	46.87	25.74
migratory langerhans cells, donor1	11901-125F2	27.25	32.24	14.59
migratory langerhans cells, donor2	11902-125F3	22.47	32.12	13.68
migratory langerhans cells, donor3	11903-125F4	36.97	51.15	20.64
mixed mullerian tumor cell line:HTMMT	10689-109F5	21.55	83.91	24.49
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	86.47	43.02	33.06
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	24.65	84.08	18.89
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	177.73	15.79	21.88
myelodysplastic syndrome cell line:SKM-1	10772-110F7	87.78	106.63	72.62
myeloma cell line:PCM6	10474-106I6	35.78	149.83	41.11
myxofibrosarcoma cell line:MFH-ino	10600-108E6	49.71	36.52	21.81
myxofibrosarcoma cell line:NMFH-1	10684-109E9	20.99	71.98	28.64
nasal epithelial cells, donor1, tech_rep1	12226-129F3	4.57	84.13	7.47
nasal epithelial cells, donor1, tech_rep2	12226-129F3	6.10	96.49	7.80
nasal epithelial cells, donor2	12227-129F4	20.42	49.13	14.35
neuroblastoma cell line:CHP-134	10508-107D4	127.22	9.20	30.14
neuroblastoma cell line:NB-1	10539-107G8	205.61	38.17	85.12
neuroblastoma cell line:NBsusSR	10607-108F4	117.46	46.61	53.35
neuroblastoma cell line:NH-12	10555-107I6	204.43	21.80	66.15
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	143.05	21.11	62.86
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	210.80	13.30	35.64
neuroectodermal tumor cell line:TASK1	10774-110F9	92.78	25.16	30.39
neuroepithelioma cell line:SK-N-MC	10728-110A8	226.33	30.52	50.86
neurofibroma cell line:Hs 53.T	10729-110A9	60.69	26.35	20.23
neutrophil PMN, donor1	12133-128D9	14.87	89.25	0.00
neutrophil PMN, donor2	12137-128E4	0.00	106.25	26.56
neutrophil PMN, donor3	12141-128E8	9.47	123.12	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	182.14	9.81	32.47
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	58.44	117.67	48.03
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	83.68	36.87	35.27
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	67.00	64.90	29.96
nucleus accumbens, adult, pool1	10037-101F1	84.18	44.62	28.03
occipital cortex - adult, donor10196	10172-103C1	96.84	55.63	26.78
occipital cortex, adult, donor10252	10163-103B1	33.28	43.47	17.44
occipital cortex, newborn, donor10223	10355-105E4	111.37	26.20	23.29
occipital lobe, adult, donor1	10076-102A4	94.46	51.95	25.45
occipital lobe, fetal, donor1	10073-102A1	102.98	25.75	70.80
occipital pole, adult, pool1	10036-101E9	70.96	54.09	32.40
olfactory region, adult	10195-103E6	66.49	48.15	21.40
optic nerve, donor1	10277-104E7	16.01	32.02	8.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	7.86	25.74	15.04
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	40.67	39.02	25.55
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	25.40	19.47	9.65
oral squamous cell carcinoma cell line:SAS	10544-107H4	56.14	52.21	23.10
osteoclastoma cell line:Hs 706.T	10704-109H2	31.16	35.57	19.99
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	94.37	19.62	31.77
osteosarcoma cell line:HS-Os-1	10558-107I9	64.47	28.20	26.93
ovary, adult, pool1	10020-101D2	25.94	26.21	22.45
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	61.05	32.45	21.45
pancreas, adult, donor1	10049-101G4	27.28	67.73	29.16
pancreatic carcinoma cell line:NOR-P1	10698-109G5	69.05	36.90	43.05
papillary adenocarcinoma cell line:8505C	10437-106E5	83.81	78.19	57.75
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	42.22	63.58	38.58
paracentral gyrus, adult, pool1	10035-101E8	72.58	54.91	26.18
parietal cortex, adult, donor10258	10373-105G4	81.47	54.32	28.63
parietal lobe - adult, donor10196	10171-103B9	84.64	38.56	29.15
parietal lobe, adult, donor10252	10157-103A4	38.77	35.63	16.82
parietal lobe, adult, pool1	10034-101E7	60.89	44.59	28.99
parietal lobe, fetal, donor1	10072-101I9	118.32	29.10	62.07
parietal lobe, newborn, donor10223	10356-105E5	106.92	34.40	28.04
parotid gland, adult	10199-103F1	14.18	52.42	12.95
penis, adult	10200-103F2	20.95	44.58	16.65
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	20.82	28.26	24.17
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	120.05	50.85	40.94
pineal gland - adult, donor10196	10179-103C8	19.35	23.87	12.90
pineal gland, adult, donor10252	10160-103A7	21.91	55.67	20.73
pineal gland, adult, donor10258	10377-105G8	30.73	55.18	15.68
pituitary gland - adult, donor10196	10180-103C9	47.55	54.64	39.46
pituitary gland, adult, donor10252	10162-103A9	27.10	65.67	34.92
pituitary gland, adult, donor10258	10378-105G9	57.03	59.59	37.45
placenta, adult, pool1	10021-101D3	37.41	29.13	16.66
plasma cell leukemia cell line:ARH-77	10840-111E3	180.23	42.24	61.05
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	14.79	40.00	9.81
pons, adult, pool1	10033-101E6	15.06	31.84	14.80
postcentral gyrus, adult, pool1	10032-101E5	72.79	56.58	31.21
promyelocytes/myelocytes PMC, donor1	12132-128D8	71.11	20.91	20.91
promyelocytes/myelocytes PMC, donor2	12136-128E3	198.29	99.14	104.65
promyelocytes/myelocytes PMC, donor3	12140-128E7	316.87	152.56	70.41
prostate cancer cell line:DU145	10490-107B4	21.70	29.57	21.41
prostate cancer cell line:PC-3	10439-106E7	83.31	88.21	58.26
prostate, adult, pool1	10022-101D4	16.60	40.36	20.04
putamen, adult, donor10196	10176-103C5	116.14	59.72	37.30
putamen, adult, donor10252	10152-102I8	64.70	72.55	27.45
putamen, adult, donor10258, tech_rep1	10372-105G3	154.09	81.96	45.90
putamen, adult, donor10258, tech_rep2	10372-105G3	97.61	62.34	30.20
putamen, newborn, donor10223	10365-105F5	32.99	41.23	17.24
rectal cancer cell line:TT1TKB	10469-106I1	7.86	23.27	10.18
rectum, fetal, donor1	10067-101I4	114.06	22.26	30.60
renal cell carcinoma cell line:OS-RC-2	10411-106B6	24.17	56.18	24.38
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	20.71	120.12	26.92
retina, adult, pool1	10030-101E3	28.23	47.31	21.17
retinoblastoma cell line:Y79	10475-106I7	139.25	45.21	55.60
rhabdomyosarcoma cell line:KYM-1	10787-110H4	101.80	29.38	43.03
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	204.43	39.65	81.83
sacrococcigeal teratoma cell line:HTST	10695-109G2	51.53	37.89	16.67
salivary acinar cells, donor1	11771-123I7	25.74	34.64	28.00
salivary acinar cells, donor2	11772-123I8	28.36	44.20	23.54
salivary acinar cells, donor3	11773-123I9	16.55	36.41	13.90
salivary gland, adult, pool1	10093-102C3	20.59	101.24	14.87
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	19.64	31.70	20.07
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	25.98	32.56	18.34
seminal vesicle, adult	10201-103F3	19.05	59.26	13.23
serous adenocarcinoma cell line:JHOS-2	10639-108I9	45.43	55.39	15.06
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	69.20	69.70	33.47
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	115.41	78.28	66.23
serous cystadenocarcinoma cell line:HTOA	10693-109F9	65.28	70.38	36.27
signet ring carcinoma cell line:Kato III	10436-106E4	17.91	60.46	24.65
signet ring carcinoma cell line:NUGC-4	10483-107A6	45.80	98.06	43.61
skeletal muscle - soleus muscle, donor1	10282-104F3	14.90	39.01	15.61
skeletal muscle, adult, pool1	10023-101D5	19.19	56.13	18.47
skeletal muscle, fetal, donor1	10066-101I3	43.22	14.07	15.08
skin, adult, donor1	10074-102A2	33.93	61.07	6.79
skin, fetal, donor1	10065-101I2	63.12	24.62	14.52
small cell cervical cancer cell line:HCSC-1	10800-110I8	128.74	48.69	68.71
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	224.43	49.80	84.48
small cell lung carcinoma cell line:DMS 144	10841-111E4	71.89	34.12	63.99
small cell lung carcinoma cell line:LK-2	10541-107H1	48.95	38.57	53.57
small cell lung carcinoma cell line:NCI-H82	10842-111E5	36.19	32.97	44.72
small cell lung carcinoma cell line:WA-hT	10562-108A4	105.69	85.86	62.11
small intestine, adult, pool1	10024-101D6	19.23	62.95	18.63
small intestine, fetal, donor1	10064-101I1	70.76	42.26	31.69
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	12.31	80.01	24.62
smooth muscle, adult, pool1	10048-101G3	11.63	22.74	6.98
somatostatinoma cell line:QGP-1	10781-110G7	5.36	29.21	9.92
spinal cord - adult, donor10196	10181-103D1	22.25	18.12	15.37
spinal cord, adult, donor10252	10159-103A6	25.63	38.64	13.80
spinal cord, adult, donor10258	10369-105F9	43.58	40.12	13.14
spinal cord, fetal, donor1	10056-101H2	71.35	27.44	32.93
spinal cord, newborn, donor10223	10359-105E8	57.40	34.44	18.83
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	52.72	31.36	16.43
spleen, adult, pool1	10025-101D7	70.16	47.03	38.44
spleen, fetal, pool1	10044-101F8	75.96	23.84	29.24
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	33.12	35.09	25.36
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	21.08	58.29	16.90
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	106.23	88.76	43.33
squamous cell carcinoma cell line:T3M-5	10616-108G4	35.57	92.65	22.67
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	31.52	165.69	27.13
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	78.37	99.12	62.27
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	64.73	38.08	51.19
stomach, fetal, donor1	10062-101H8	72.62	52.33	28.84
submaxillary gland, adult	10202-103F4	22.79	74.06	14.81
substantia nigra - adult, donor10196	10178-103C7	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	19.94	43.20	11.01
substantia nigra, adult, donor10258	10371-105G2	45.00	63.10	19.66
substantia nigra, newborn, donor10223	10358-105E7	48.75	26.85	15.54
synovial sarcoma cell line:HS-SY-II	10441-106E9	102.94	38.98	64.65
temporal lobe, adult, pool1	10031-101E4	88.33	55.19	31.28
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	128.21	22.79	60.54
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	119.99	37.80	45.27
tenocyte, donor1	11763-123H8	37.00	44.34	20.25
tenocyte, donor2	11765-123I1	31.28	52.27	25.56
tenocyte, donor3	11768-123I4	34.84	45.96	23.35
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	231.49	20.06	75.97
teratocarcinoma cell line:NCR-G1	10798-110I6	339.74	57.81	103.74
teratocarcinoma cell line:PA-1	10807-111A6	245.79	23.25	69.74
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	80.48	17.39	22.34
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	82.82	23.07	48.03
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	22.47	9.92	8.51
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	183.04	34.85	77.52
testis, adult, pool1	10026-101D8	35.11	28.67	29.63
testis, adult, pool2	10096-102C6	76.68	41.95	48.27
thalamus - adult, donor10196	10168-103B6	33.12	25.39	17.66
thalamus, adult, donor10252	10154-103A1	28.29	38.13	16.25
thalamus, adult, donor10258, tech_rep1	10370-105G1	61.58	100.08	20.02
thalamus, adult, donor10258, tech_rep2	10370-105G1	25.53	30.30	17.29
thalamus, newborn, donor10223	10366-105F6	40.27	27.04	15.53
throat, adult	10209-103G2	21.97	57.17	13.48
throat, fetal, donor1	10061-101H7	77.40	27.73	35.35
thymic carcinoma cell line:Ty-82	10803-111A2	180.85	31.40	64.19
thymus, adult, pool1	10027-101D9	104.19	17.70	34.80
thymus, fetal, pool1	10043-101F7	91.64	18.91	32.94
thyroid carcinoma cell line:KHM-5M	10776-110G2	74.59	49.46	47.60
thyroid carcinoma cell line:TCO-1	10783-110G9	81.44	77.81	65.38
thyroid, adult, pool1	10028-101E1	53.84	68.68	38.72
thyroid, fetal, donor1	10060-101H6	70.66	36.91	29.53
tongue epidermis (fungiform papillae), donor1	10288-104F9	18.48	33.88	6.16
tongue, adult	10203-103F5	17.21	42.10	14.65
tongue, fetal, donor1	10059-101H5	45.71	31.53	29.95
tonsil, adult, pool1	10047-101G2	60.51	51.69	30.65
trachea, adult, pool1	10029-101E2	30.18	55.05	29.86
trachea, fetal, donor1	10058-101H4	63.47	33.08	18.08
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	132.85	40.03	31.88
transitional-cell carcinoma cell line:5637	10418-106C4	87.44	52.08	54.10
transitional-cell carcinoma cell line:JMSU1	10492-107B6	68.63	96.52	55.31
tridermal teratoma cell line:HGRT	10694-109G1	102.74	13.32	26.64
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	46.05	23.19	18.79
umbilical cord, fetal, donor1	10057-101H3	35.47	25.04	18.78
uterus, adult, pool1	10100-102D1	37.71	33.27	20.65
uterus, fetal, donor1	10055-101H1	79.86	18.43	25.60
vagina, adult	10204-103F6	10.99	29.08	15.51
vein, adult	10191-103E2	64.88	39.02	23.45
xeroderma pigentosum b cell line:XPL 17	10563-108A5	134.85	44.60	35.25